283 related articles for article (PubMed ID: 30903273)
1. SOX10 expression in mammary invasive ductal carcinomas and benign breast tissue.
Chiu K; Ionescu DN; Hayes M
Virchows Arch; 2019 Jun; 474(6):667-672. PubMed ID: 30903273
[TBL] [Abstract][Full Text] [Related]
2. Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas.
Cimino-Mathews A; Subhawong AP; Elwood H; Warzecha HN; Sharma R; Park BH; Taube JM; Illei PB; Argani P
Hum Pathol; 2013 Jun; 44(6):959-65. PubMed ID: 23260325
[TBL] [Abstract][Full Text] [Related]
3. Utility of Sox10 labeling in metastatic breast carcinomas.
Nelson ER; Sharma R; Argani P; Cimino-Mathews A
Hum Pathol; 2017 Sep; 67():205-210. PubMed ID: 28843711
[TBL] [Abstract][Full Text] [Related]
4. The Utility of SOX10 Immunohistochemical Staining in Breast Pathology.
Rammal R; Goel K; Elishaev E; Rinda Soong T; Jones MW; Zhao C; Clark BZ; Carter GJ; Yu J; Fine JL; Villatoro TM; Harinath L; Bhargava R
Am J Clin Pathol; 2022 Nov; 158(5):616-625. PubMed ID: 36000970
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological, immunohistochemical and molecular correlation of neural crest transcription factor SOX10 expression in triple-negative breast carcinoma.
Harbhajanka A; Chahar S; Miskimen K; Silverman P; Harris L; Williams N; Varadan V; Gilmore H
Hum Pathol; 2018 Oct; 80():163-169. PubMed ID: 29894722
[TBL] [Abstract][Full Text] [Related]
6. A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas.
Tacha D; Qi W; Ra S; Bremer R; Yu C; Chu J; Hoang L; Robbins B
Arch Pathol Lab Med; 2015 Apr; 139(4):530-6. PubMed ID: 25436903
[TBL] [Abstract][Full Text] [Related]
7. Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors.
Miettinen M; McCue PA; Sarlomo-Rikala M; Biernat W; Czapiewski P; Kopczynski J; Thompson LD; Lasota J; Wang Z; Fetsch JF
Am J Surg Pathol; 2015 Jun; 39(6):826-35. PubMed ID: 25724000
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics of the SOX10+ subset of HER2+ breast cancer.
Weisman P; Yu Q; Xu J
Ann Diagn Pathol; 2023 Apr; 63():152087. PubMed ID: 36669230
[TBL] [Abstract][Full Text] [Related]
9. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
Hsieh MS; Lee YH; Chang YL
Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192
[TBL] [Abstract][Full Text] [Related]
10. SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis.
Ohtomo R; Mori T; Shibata S; Tsuta K; Maeshima AM; Akazawa C; Watabe Y; Honda K; Yamada T; Yoshimoto S; Asai M; Okano H; Kanai Y; Tsuda H
Mod Pathol; 2013 Aug; 26(8):1041-50. PubMed ID: 23558573
[TBL] [Abstract][Full Text] [Related]
11. TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma.
Yoon EC; Wang G; Parkinson B; Huo L; Peng Y; Wang J; Salisbury T; Wu Y; Chen H; Albarracin CT; Resetkova E; Middleton LP; Krishnamurthy S; Gan Q; Sun H; Huang X; Shen T; Chen W; Parwani AV; Sahin AA; Li Z; Ding Q
Hum Pathol; 2022 Jul; 125():97-107. PubMed ID: 35413381
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells.
Popnikolov NK; Cavone SM; Schultz PM; Garcia FU
Mod Pathol; 2005 Dec; 18(12):1535-41. PubMed ID: 16258511
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and Functional Characterization of Ductal Carcinoma In Situ-Associated Myoepithelial Cells.
Rohilla M; Bal A; Singh G; Joshi K
Clin Breast Cancer; 2015 Oct; 15(5):335-42. PubMed ID: 25700939
[TBL] [Abstract][Full Text] [Related]
14. LKB1 protein expression in human breast cancer.
Fenton H; Carlile B; Montgomery EA; Carraway H; Herman J; Sahin F; Su GH; Argani P
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):146-53. PubMed ID: 16785781
[TBL] [Abstract][Full Text] [Related]
15. Combined use of SOX10 and GATA3 in mammary carcinoma.
Qazi MS; McGregor SM
Pathol Res Pract; 2020 Feb; 216(2):152801. PubMed ID: 31924335
[TBL] [Abstract][Full Text] [Related]
16. A SOX10+/AR- immunoprofile may identify a subset of low positive ER carcinomas with a wider range of ER expression.
Keske A; Shetty S; Weisman P; Yu Q; McGregor SM; Xu J
Pathol Res Pract; 2023 Aug; 248():154628. PubMed ID: 37399589
[TBL] [Abstract][Full Text] [Related]
17. p53 alteration in morphologically normal/benign breast tissue in patients with triple-negative high-grade breast carcinomas: breast p53 signature?
Wang X; Stolla M; Ring BZ; Yang Q; Laughlin TS; Rothberg PG; Skinner K; Hicks DG
Hum Pathol; 2016 Sep; 55():196-201. PubMed ID: 27246177
[TBL] [Abstract][Full Text] [Related]
18. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas.
Ivanov SV; Panaccione A; Nonaka D; Prasad ML; Boyd KL; Brown B; Guo Y; Sewell A; Yarbrough WG
Br J Cancer; 2013 Jul; 109(2):444-51. PubMed ID: 23799842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
